>Go!

Warner Chilcott Acquisition

Warner Chilcott Acquisition

On October 1, 2013, Actavis completed the acquisition of Warner Chilcott plc, creating a premier global specialty pharmaceutical leader in Women’s Health and Urology, and with a solid foundation in Gastroenterology (GI) and Dermatology. The combination more than doubled the size of Actavis Specialty Brands’ portfolio, principally marketed in the United States and Canada, and strengthened its industry-leading pipeline to more than 25 products in various stages of development.

When combined with the expansive 60+ market global commercial powerhouse of Actavis Pharma and the industry-leading manufacturing capabilities of Actavis Global Operations, we now operate a truly formidable specialty pharmaceutical company – and continue to drive exceptional value for our shareholders, customers and employees.

Frequently asked questions for shareholders (PDF)

Form 8937 for Actavis (PDF).
 

Press Releases

01 OCT 2013
Actavis Completes Warner Chilcott Acquisition

30 SEP 2013
Actavis and Warner Chilcott Receive Approval from Irish High Court For Pending Warner Chilcott Acquisition

27 SEP 2013
Actavis and Warner Chilcott Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Warner Chilcott

10 SEP 2013
Actavis and Warner Chilcott Shareholders Approve Proposals Related to Actavis' Proposed Acquisition of Warner Chilcott

29 AUG 2013
Actavis' Proposed Acquisition of Warner Chilcott Recommended for Approval by Leading Proxy Advisory Firms

09 AUG 2013
Actavis Receives Approval from French Competition Authority for Pending Warner Chilcott Acquisition

02 AUG 2013
Actavis Announces New Senior Unsecured Term Loan Credit and Guaranty Agreement

31 JUL 2013
Actavis and Warner Chilcott Announce Effectiveness of Registration Statement on Form S-4

11 JUL 2013
Actavis and Warner Chilcott Receive FTC Second Request Under Hart-Scott-Rodino

18 JUN 2013
Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition

20 MAY 2013
Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company

14 MAY 2013
Announcement Under Irish Takeover Rules Relevant Securities in Issue

10 MAY 2013
Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc


Investor Contact:

Lisa DeFrancesco
+1 (862) 261-7152
investor.relations@actavis.com


Media Contact:

Mark Marmur
+1 (862) 261-8030
media.relations@actavis.com